Biogen Inc. (ETR: IDP)
Germany
· Delayed Price · Currency is EUR
141.85
-2.20 (-1.53%)
Dec 19, 2024, 9:09 AM CET
Biogen Employees
Biogen had 7,570 employees as of December 31, 2023. The number of employees decreased by 1,155 or -13.24% compared to the previous year.
Employees
7,570
Change (1Y)
-1,155
Growth (1Y)
-13.24%
Revenue / Employee
€1,137,924
Profits / Employee
€191,306
Market Cap
20.49B
Employees Chart
Employees History
Biogen News
- 9 days ago - Private Medicare plans must cover Biogen's ALS drug, US agency says - Reuters
- 10 days ago - Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory? - Benzinga
- 12 days ago - Biogen downgraded to hold by Jefferies, Ocrevus royalties cited - Seeking Alpha
- 12 days ago - Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown - Benzinga
- 16 days ago - “Laggard” stocks with expanding FCF margins and attractive FCF yields – Goldman - Seeking Alpha
- 16 days ago - GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners - Wallstreet:Online
- 16 days ago - GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners - Business Wire
- 17 days ago - Biogen Inc (BIIB) and Eisai's Alzheimer's Drug LEQEMBI Approved in Mexico - GuruFocus